Indogulf Cropsciences quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	169	189	−11.0%
EBITDA	9.6	9.9	−3.7%
EBITDA margin	5.7%	5.2%	+0.4 pts
Profit before tax	3.1	4.6	−32.8%
Net profit	2.4	3.9	−37.6%
EPS	₹0.38	₹0.80	−52.5%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025

Expenses
	169	151	116	248	189	126
	0.9	2.0	2.5	2.0	0.9	1.9
	169	153	119	250	190	128
	147	102	83.0	158	168	137
	9.0	15.8	7.4	7.6	16.2	2.5
	−33.6	−27.8	−17.1	9.8	−36.6	−65.5
	13.7	15.6	13.9	14.5	12.7	11.5
	4.5	4.4	4.3	4.6	3.8	4.1
	2.8	3.7	2.7	2.6	2.4	3.5
	23.3	24.7	17.1	26.6	19.1	19.5
	166	139	111	224	186	113
	9.6	20.4	11.7	32.0	9.9	20.8
	6.8	16.7	9.0	29.4	7.5	17.4
Profit
	3.2	14.3	7.2	26.8	4.6	15.2
	−0.0	−0.4	0.2	0.4	0.0	0.0
	3.1	13.9	7.4	27.1	4.6	15.2
	0.8	4.1	2.5	7.8	−0.4	5.9
	−0.1	−1.8	1.0	−1.4	1.2	−0.6
	0.7	2.3	3.5	6.4	0.8	5.4
	2.4	11.6	3.9	20.7	3.9	9.8
	2.4	11.6	3.9	20.7	3.9	9.8
	0.1	0.2	0.0	0.0	0.0	0.1
	2.5	11.8	3.9	20.7	3.9	9.9
	—	—	—	—	3.9	—
Per share
	₹0.38	₹2.30	₹0.77	₹1.73	₹0.80	₹2.10
	₹0.38	₹2.30	₹0.77	₹1.73	₹0.80	₹2.10
Other comprehensive income — detail
	0.1	0.2	0.0	0.0	0.0	0.1
	0.1	0.3	0.0	0.0	0.0	0.1
	0.0	0.1	0.0	0.0	0.0	0.0
	—	—	—	—	3.9	—
Per share — as-filed variants
	₹0.38	₹2.30	₹0.77	₹1.73	₹0.80	₹2.10
	₹0.38	₹2.30	₹0.77	₹1.73	₹0.80	₹2.10
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	46.6	60.6	42.8	73.1	41.7	51.9
	27.6%	40.2%	36.8%	29.4%	22.0%	41.1%
Adjusted (ex-exceptional items) — derived
	3.2	14.3	7.2	26.8	4.6	15.2
	−0.0	−0.4	0.2	0.4	0.0	0.0
	2.4	11.9	3.8	20.4	3.9	9.8
	₹0.38	₹2.36	₹0.75	₹1.71	₹0.80	₹2.10

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

IGCL₹58.54

Indogulf Cropsciences Limited

· Chemicals

Annual Quarterly₹ CrorePeersBESTAGRO HERANBA ADVANCE DHARMAJ ASTEC PUNJABCHEM MOL IPLMcap ₹370 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	126.2	189.4	248.3	116.1	150.8	168.5
Other Income	1.9	0.9	2.0	2.5	2.0	0.9
Total Income	128.2	190.3	250.3	118.6	152.8	169.4
Expenses
+ Cost of Materials Consumed	137.3	168.1	157.9	83.0	102.2	146.6
+ Purchases of Stock-in-Trade	2.5	16.2	7.6	7.4	15.8	9.0
+ Changes in Inventories	-65.5	-36.6	9.8	-17.1	-27.8	-33.6
+ Employee Benefit Expense	11.5	12.7	14.5	13.9	15.6	13.7
+ Finance Costs	4.1	3.8	4.6	4.3	4.4	4.5
+ Depreciation & Amortisation	3.5	2.4	2.6	2.7	3.7	2.8
+ Other Expenses	19.5	19.1	26.6	17.1	24.7	23.3
Total Expenses	113.0	185.7	223.5	111.4	138.5	166.3
EBITDA	20.8	9.9	32.0	11.7	20.4	9.6
EBIT	17.4	7.5	29.4	9.0	16.7	6.8
Profit
PBT before Exceptional Items	15.2	4.6	26.8	7.2	14.3	3.2
+ Exceptional Items	0.0	0.0	0.4	0.2	-0.4	-0.0
Pretax Income	15.2	4.6	27.1	7.4	13.9	3.1
+ Current Tax	5.9	-0.4	7.8	2.5	4.1	0.8
+ Deferred Tax	-0.6	1.2	-1.4	1.0	-1.8	-0.1
Tax Expense	5.4	0.8	6.4	3.5	2.3	0.7
Net Income	9.8	3.9	20.7	3.9	11.6	2.4
+ Net Income — Continuing Ops	9.8	3.9	20.7	3.9	11.6	2.4
+ Other Comprehensive Income	0.1	0.0	0.0	0.0	0.2	0.1
Total Comprehensive Income	9.9	3.9	20.7	3.9	11.8	2.5
Net Income to Common	—	3.9	—	—	—	—
Per Share
Basic EPS	2.10	0.80	1.73	0.77	2.30	0.38
Diluted EPS	2.10	0.80	1.73	0.77	2.30	0.38
Other Comprehensive Income — detail
+ Other Comprehensive Income	0.1	0.0	0.0	0.0	0.2	0.1
+ Items NOT to be Reclassified to P&L	0.1	0.0	0.0	0.0	0.3	0.1
+ Tax on Items NOT to be Reclassified	0.0	0.0	0.0	0.0	0.1	0.0
Comprehensive Income — Owners of Parent	—	3.9	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.10	0.80	1.73	0.77	2.30	0.38
Diluted EPS — Continuing Operations	2.10	0.80	1.73	0.77	2.30	0.38
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	51.9	41.7	73.1	42.8	60.6	46.6
Gross Margin %	41.11	22.00	29.44	36.84	40.17	27.64
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	15.2	4.6	26.8	7.2	14.3	3.2
− Exceptional Items (reconciliation)	0.0	0.0	0.4	0.2	-0.4	-0.0
Net Income Adj (tax-effected)	9.8	3.9	20.4	3.8	11.9	2.4
EPS Adj	2.10	0.80	1.71	0.75	2.36	0.38
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	48.8	48.8	63.2	63.2	63.2	63.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Indogulf Cropsciences Q2 FY27 results date

Indogulf Cropsciences (NSE: IGCL) will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, according to the board-meeting notice it filed on 28 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹2.4 crore, down 37.6% from ₹3.9 crore in Q1 FY26 and down 79.2% from ₹11.6 crore in Q4 FY26. Revenue from operations was ₹169 crore, down 11.0% year on year and up 11.8% from the previous quarter.

Board-meeting notice filed: 28 October 2026
Q2 FY26 results (a year earlier): 12 November 2025
Q1 FY27 results (the latest): 12 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 2 November 2026Monday · notice filed 28 Oct
Q1 FY27 net profit: ₹2.4 Cr−37.6% vs Q1 FY26−79.2% vs Q4 FY26
Q1 FY27 revenue: ₹169 Cr−11.0% vs Q1 FY26+11.8% vs Q4 FY26
Q1 FY27 operating margin: 4.0%+0.1 pts vs Q1 FY26−7.0 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹20.7 CrRevenue ₹248 Cr
Q1 FY27 EPS (basic): ₹0.38

Questions

When will Indogulf Cropsciences announce its Q2 FY27 results?

On 2 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 28 October 2026). Last year it reported Q2 FY26 on 12 November 2025.

What will Indogulf Cropsciences' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹20.7 crore and revenue from operations ₹248 crore. The latest quarter, Q1 FY27, had a net profit of ₹2.4 crore and revenue of ₹169 crore.

What were Indogulf Cropsciences' Q1 FY27 results?

Consolidated net profit was ₹2.4 crore, down 37.6% from ₹3.9 crore in Q1 FY26 and down 79.2% from ₹11.6 crore in Q4 FY26. Revenue from operations was ₹169 crore, down 11.0% year on year and up 11.8% from the previous quarter.

How has Indogulf Cropsciences' profit changed over the last four quarters?

Net profit by quarter: ₹20.7 crore in Q2 FY26, ₹3.9 crore in Q3 FY26, ₹11.6 crore in Q4 FY26 and ₹2.4 crore in Q1 FY27. That is ₹38.6 crore over the four quarters. Revenue from operations: ₹248 crore, ₹116 crore, ₹151 crore and ₹169 crore.

What was Indogulf Cropsciences' net profit in FY26?

Consolidated net profit was ₹40 crore in FY26 (April 2025–March 2026), up 27.2% from ₹31.5 crore in FY25.

What was Indogulf Cropsciences' revenue in FY26?

Revenue from operations was ₹705 crore in FY26 (April 2025–March 2026), up 19.3% from ₹590 crore in FY25.

Where do these Indogulf Cropsciences figures come from?

From Indogulf Cropsciences' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.